![Jean-Michel Hotton](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jean-Michel Hotton
Geen lopende functies
Profiel
Jean-Michel Hotton worked as a Director of Pharmaco Economic Affairs at Pfizer Inc. and as a Director at Fluxome Sciences A.
Eerdere bekende functies van Jean-Michel Hotton
Bedrijven | Functie | Einde |
---|---|---|
Fluxome Sciences A/S
![]() Fluxome Sciences A/S BiotechnologyHealth Technology Fluxome, a Copenhagen-based Danish company, is a recognized leader in the field of industrial biotechnology. Fluxome uses its proprietary, cutting-edge microbial metabolic engineering technology platform to build highly efficient cell factories for the production of a broad range of commercially important nutraceutical ingredients. Fluxome's technology allows the company to rapidly develop and commercialize high purity, natural products manufactured using cost-effective bioprocesses. | Directeur/Bestuurslid | 08-08-2013 |
PFIZER, INC. | Corporate Officer/Principal | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
PFIZER, INC. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Fluxome Sciences A/S
![]() Fluxome Sciences A/S BiotechnologyHealth Technology Fluxome, a Copenhagen-based Danish company, is a recognized leader in the field of industrial biotechnology. Fluxome uses its proprietary, cutting-edge microbial metabolic engineering technology platform to build highly efficient cell factories for the production of a broad range of commercially important nutraceutical ingredients. Fluxome's technology allows the company to rapidly develop and commercialize high purity, natural products manufactured using cost-effective bioprocesses. | Health Technology |